Original Research

Published on 30 Mar 2023

Clinical characterization and genomic landscape of gynecological cancers among patients attending a Chinese hospital

in Gynecological Oncology

Cen Jiang
Yiyi Lu
Hua Liu
Gang Cai
Zhao Peng
Weiwei Feng
Lin Lin

Frontiers in Oncology

doi 10.3389/fonc.2023.1143876

2,474 views
1 citation

Original Research

Published on 29 Mar 2023

HPV genotyping of cervical histologic specimens of 61, 422 patients from the largest women hospital in China

in Gynecological Oncology

Fangfang Zhong
Zaibo Li
Yihua Sun
Yaoxing Xiao
Juan Li
Xianrong Zhou
Qing Cong
Long Sui
Xiang Tao
Chengquan Zhao

Frontiers in Oncology

doi 10.3389/fonc.2023.1161631

4,382 views
6 citations

Original Research

Published on 29 Mar 2023

How do serum lipid levels change and influence progression-free survival in epithelial ovarian cancer patients receiving bevacizumab treatment?

in Gynecological Oncology

Xiaoyu Huang
Yong Huang
Ping Li

Frontiers in Oncology

doi 10.3389/fonc.2023.1168996

1,609 views

Original Research

Published on 22 Mar 2023

Lymphocyte-to-monocyte ratio after primary surgery is an independent prognostic factor for patients with epithelial ovarian cancer: A propensity score matching analysis

in Gynecological Oncology

Qian Hu
Guihua Shen
Ye Li
Ya Xie
Xiao Ma
Lijuan Jiang
Qiubo Lv

Frontiers in Oncology

doi 10.3389/fonc.2023.1139929

1,254 views
3 citations

Original Research

Published on 17 Mar 2023

Clinical significance of enlarged cardiophrenic lymph nodes by CT in advanced ovarian cancer

in Gynecological Oncology

Sisi Song
Huizhu Chen
Gang Ning
Yingkun Guo
Xuesheng Li

Frontiers in Oncology

doi 10.3389/fonc.2023.1149139

3,820 views
2 citations

Review

Published on 17 Mar 2023

A comprehensive overview of exosome lncRNAs: Emerging biomarkers and potential therapeutics in gynecological cancers

in Gynecological Oncology

Min Wang
Lulu Fu
Ying Xu
Shuai Ma
Xueying Zhang
Lianwen Zheng

Frontiers in Oncology

doi 10.3389/fonc.2023.1138142

3,148 views
2 citations

Case Report

Published on 13 Mar 2023

Case Report: A case of COL1A1–PDGFB fusion uterine sarcoma at cervix and insights into the clinical management of rare uterine sarcoma

in Gynecological Oncology

Linghui Lu
Shunni Wang
Haoran Shen
Feiran Zhang
Fenghua Ma
Yue Shi
Yan Ning

Frontiers in Oncology

doi 10.3389/fonc.2023.1108586

2,231 views
6 citations

Original Research

Published on 10 Mar 2023

Prognostic value of β-Arrestins in combination with glucocorticoid receptor in epithelial ovarian cancer

in Gynecological Oncology

Ji-Won Ryu
Ha-Yeon Shin
Hyo-Sun Kim
Gwan Hee Han
Jeong Won Kim
Hae-Nam Lee
Hanbyoul Cho
Joon-Yong Chung
Jae-Hoon Kim

Frontiers in Oncology

doi 10.3389/fonc.2023.1104521

1,821 views

Original Research

Published on 09 Mar 2023

Cervical cancer prevention program in Mexico disrupted due to COVID-19 pandemic: Challenges and opportunities

in Gynecological Oncology

Aurelio Cruz-Valdez
Lina Sofia Palacio-Mejía
Amado D. Quezada-Sánchez
Juan Eugenio Hernández-Ávila
Tatiana Galicia-Carmona
Lucely del Carmen Cetina-Pérez
Eder A. Arango-Bravo
David Isla-Ortiz
Carlos E. Aranda-Flores
Santos-Regino Uscanga-Sánchez

Frontiers in Oncology

doi 10.3389/fonc.2023.1008560

3,928 views
5 citations

Editorial

Published on 09 Mar 2023

Editorial: Methods in gynecological oncology

in Gynecological Oncology

Federica Perelli
Alberto Mattei
Giovanni Scambia
Anna Franca Cavaliere

Frontiers in Oncology

doi 10.3389/fonc.2023.1167088

1,921 views
22 citations

Original Research

Published on 09 Mar 2023

Management of patients with recurrent/metastatic endometrial cancer: Consensus recommendations from an expert panel from Brazil

in Gynecological Oncology

Diocésio Alves Pinto de Andrade
Andréa Paiva Gadelha Guimarães
Andréia Cristina de Melo
Angélica Nogueira-Rodrigues
Larissa Müller Gomes
Mariana Scaranti
Joyce Maria Lisboa Maia
Alessandra Menezes Morelle
Candice Amorim de Araújo Lima Santos
Cristiano de Pádua Souza

Frontiers in Oncology

doi 10.3389/fonc.2023.1133277

2,300 views
1 citation

Original Research

Published on 08 Mar 2023

The association of Wnt-signalling and EMT markers with clinical characteristics in women with endometrial cancer

in Gynecological Oncology

Živa Ledinek
Monika Sobočan
Damjan Sisinger
Marko Hojnik
Tomaž Büdefeld
Uroš Potočnik
Jure Knez

Frontiers in Oncology

doi 10.3389/fonc.2023.1013463

1,905 views
2 citations

Original Research

Published on 03 Mar 2023

The inhibitory effect of 6-gingerol and cisplatin on ovarian cancer and antitumor activity: In silico, in vitro, and in vivo

in Gynecological Oncology

Zohreh Salari
Ahmad Khosravi
Elham Pourkhandani
Elaheh Molaakbari
Ehsan Salarkia
Alireza Keyhani
Iraj Sharifi
Hadi Tavakkoli
Samira Sohbati
Shahriar Dabiri

Frontiers in Oncology

doi 10.3389/fonc.2023.1098429

3,519 views
7 citations

Original Research

Published on 03 Mar 2023

ImmuneScore of eight-gene signature predicts prognosis and survival in patients with endometrial cancer

in Gynecological Oncology

Jiahui Gu
Zihao Wang
B. O. Wang
Xiaoxin Ma

Frontiers in Oncology

doi 10.3389/fonc.2023.1097015

2,287 views
2 citations

Original Research

Published on 27 Feb 2023

PARP inhibitor-related haemorrhages: What does the real-world study say?

in Gynecological Oncology

Shiyan Wang
Mengran Guo
Xiang Zhang
Ping Fan
Zhaohui Jin

Frontiers in Oncology

doi 10.3389/fonc.2023.1070343

2,651 views
3 citations

Original Research

Published on 22 Feb 2023

PARP inhibitors in the treatment of ARID1A mutant ovarian clear cell cancer: PI3K/Akt1-dependent mechanism of synthetic lethality

in Gynecological Oncology

Vasily A. Yakovlev
Stephanie A. Sullivan
Emma C. Fields
Sarah M. Temkin

Frontiers in Oncology

doi 10.3389/fonc.2023.1124147

4,379 views
3 citations

Navigation group

Articles

Clinical characterization and genomic landscape of gynecological cancers among patients attending a Chinese hospital

HPV genotyping of cervical histologic specimens of 61, 422 patients from the largest women hospital in China

How do serum lipid levels change and influence progression-free survival in epithelial ovarian cancer patients receiving bevacizumab treatment?

Lymphocyte-to-monocyte ratio after primary surgery is an independent prognostic factor for patients with epithelial ovarian cancer: A propensity score matching analysis

Clinical significance of enlarged cardiophrenic lymph nodes by CT in advanced ovarian cancer

A comprehensive overview of exosome lncRNAs: Emerging biomarkers and potential therapeutics in gynecological cancers

Case Report: A case of COL1A1–PDGFB fusion uterine sarcoma at cervix and insights into the clinical management of rare uterine sarcoma

Prognostic value of β-Arrestins in combination with glucocorticoid receptor in epithelial ovarian cancer

Cervical cancer prevention program in Mexico disrupted due to COVID-19 pandemic: Challenges and opportunities

Editorial: Methods in gynecological oncology

Management of patients with recurrent/metastatic endometrial cancer: Consensus recommendations from an expert panel from Brazil

The association of Wnt-signalling and EMT markers with clinical characteristics in women with endometrial cancer

The inhibitory effect of 6-gingerol and cisplatin on ovarian cancer and antitumor activity: In silico, in vitro, and in vivo

ImmuneScore of eight-gene signature predicts prognosis and survival in patients with endometrial cancer

PARP inhibitor-related haemorrhages: What does the real-world study say?

PARP inhibitors in the treatment of ARID1A mutant ovarian clear cell cancer: PI3K/Akt1-dependent mechanism of synthetic lethality